Travere Therapeutics (TVTX) Shares Issued (2016 - 2025)
Historic Shares Issued for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $4.1 million.
- Travere Therapeutics' Shares Issued changed N/A to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year increase of 1078194.34%. This contributed to the annual value of $134.7 million for FY2024, which is 2952.96% down from last year.
- Travere Therapeutics' Shares Issued amounted to $4.1 million in Q3 2025.
- In the past 5 years, Travere Therapeutics' Shares Issued ranged from a high of $182.6 million in Q4 2021 and a low of $122000.0 during Q1 2022
- In the last 5 years, Travere Therapeutics' Shares Issued had a median value of $2.8 million in 2022 and averaged $27.8 million.
- Per our database at Business Quant, Travere Therapeutics' Shares Issued tumbled by 9970.65% in 2021 and then surged by 2008852.46% in 2023.
- Over the past 5 years, Travere Therapeutics' Shares Issued (Quarter) stood at $182.6 million in 2021, then tumbled by 98.45% to $2.8 million in 2022, then surged by 771.86% to $24.6 million in 2023, then surged by 441.74% to $133.4 million in 2024, then plummeted by 96.93% to $4.1 million in 2025.
- Its Shares Issued was $4.1 million in Q3 2025, compared to $463000.0 in Q2 2025 and $4.2 million in Q1 2025.